The above results of ours suggest that B-cell ST6Gal1 and Neu1 probably involve in the pathophysiology of disease remission in RA through modulation of the α-2,6 SIA content in IgG (or IgG autoantibodies). This evidence concerns the gene ST6GAL1 and rheumatoid arthritis.